Kimberly-Clark Corporation

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Kimberly-Clark Corporation sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 1 currently recruiting 10 completed later-stage tilt top decile by trial count

Kimberly-Clark Corporation: 11 sponsored US clinical trials, 1 recruiting.

Kimberly-Clark Corporation sponsors 11 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 10 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diaper Rash, with 1 trials.

Top-decile sponsor footprint

Kimberly-Clark Corporation ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

10 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

11 total, page 1 of 1

RECRUITING NA

Tampon Safety-in-Use Study

NCT07561905
COMPLETED NA

Tampon Design Validation Study

NCT05553600
COMPLETED

Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation

NCT03346447
COMPLETED

Micro-Technique Sampling

NCT03242577
COMPLETED

BM Characterization Pilot

NCT03138057
COMPLETED NA

Infant Fecal Insult Study

NCT02979210
COMPLETED

Infant Microbiome in Diaper Rash

NCT02893501
COMPLETED NA

A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants

NCT02615912
COMPLETED

BM Collection From NICU Infants for Composition

NCT02570698
COMPLETED

Nasal Swab Study to Explore the Nasal Microbia

NCT02535442
COMPLETED Phase 4

Study of the Combination of a Cyanoacrylate and Surgical Solutions in Reducing Skin Flora Contamination

NCT00467857

Phase Distribution

PhaseTrial count
Phase 4 1

Therapeutic Areas

Diaper Rash 1
Dermatitis 1

Where Kimberly-Clark Corporation enrollment is open (later-stage tilt)

1 recruiting of 11 indexed (9% open); 10 completed (91%).

Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Diaper Rash (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Kimberly-Clark Corporation: open-pipeline peers nationwide

Peers matched on 11 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Kimberly-Clark Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080 0%2%4%6%8%10% Total trials Recruiting share Kimberly-Clark CorporationAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeAlkermesDBV TechnologiesFlorida Gulf Coast UniversityGenfit
Kimberly-Clark Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Kimberly-Clark Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Kimberly-Clark Corporation page

11 registered trials is a research-attention snapshot, not an endorsement of Kimberly-Clark Corporation or any single study.

  • 1 of Kimberly-Clark Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Diaper Rash is the condition Kimberly-Clark Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diaper Rash trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Kimberly-Clark Corporation pipeline card: 11 registered trials from official public datasets.Report a data error.